Skip to content

Acupuncture for Migraine: a Functional Magnetic Resonance Imaging (fMRI) Study

Acupuncture Treatment for Migraine: a Functional Magnetic Resonance Imaging Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01152632
Enrollment
100
Registered
2010-06-29
Start date
2010-01-31
Completion date
2013-12-31
Last updated
2014-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine

Keywords

acupuncture, migraine, specific acupoints, brain network

Brief summary

Selecting acupoints along meridians is the predominant principle in acupuncture treatment, and it is also considered to ensure acupuncture efficacy. This experiment is to investigate whether specific brain networks gradually come in formation in accordance with this kind of acupoint selection methods.

Detailed description

Every participants in the four intervention groups will go through functional magnetic imaging (fMRI) scan four times: the 1st scan will be performed at their baselines; the 2nd scan will be done after 2 courses (10 times) acupuncture treatment; the 3rd scan will be performed when the 4 courses end; the 4th scan will be operated after three-month enrollment. Volunteers in waiting list group will undergo the above scans at the same time points in exception of acupuncture treatment.

Interventions

thirty minutes duration every time, five times per week for one course, a total four courses

Sponsors

Chengdu University of Traditional Chinese Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
17 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* clinical diagnosis of non-aura Migraine formulated by the international headache society in 2004

Exclusion criteria

* people with other types of headache * people with organic cerebral disorders * people with primary disorders * people in moderate or severe anxiety or depression * people in pregnancy

Design outcomes

Primary

MeasureTime frame
improvement of headache frequency4 weeks

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026